2018
DOI: 10.1186/s10194-018-0932-5
|View full text |Cite
|
Sign up to set email alerts
|

Accuracy of the painDETECT screening questionnaire for detection of neuropathic components in hospital-based patients with orofacial pain: a prospective cohort study

Abstract: BackgroundBetter tools are required for the earlier identification and management of orofacial pain with different aetiologies. The painDETECT questionnaire is a patient-completed screening tool with utility for identification of neuropathic pain in a range of contexts. 254 patients, referred from primary care for management of orofacial pain and attending a secondary care centre, were prospectively recruited, and completed the painDETECT prior to consultation. The aim of this study was to determine the accura… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(17 citation statements)
references
References 26 publications
0
17
0
Order By: Relevance
“…Another study explored the accuracy of the questionnaire painDETECT to detect neuropathic components of orofacial pain when compared with a reference standard of clinical diagnosis. According to the results of that study, painDETECT, as well as other generic screening tools, must be adapted and revalidated specifically for orofacial pain patients [ 26 ]. Our results reinforce the need for more detailed and intuitive scoring of 3D pain area and intensity combined, even within body subregions such as GeoPain’s PAINS, which provides a better assessment of the sensory-discriminative pain severity status quo in real time.…”
Section: Discussionmentioning
confidence: 99%
“…Another study explored the accuracy of the questionnaire painDETECT to detect neuropathic components of orofacial pain when compared with a reference standard of clinical diagnosis. According to the results of that study, painDETECT, as well as other generic screening tools, must be adapted and revalidated specifically for orofacial pain patients [ 26 ]. Our results reinforce the need for more detailed and intuitive scoring of 3D pain area and intensity combined, even within body subregions such as GeoPain’s PAINS, which provides a better assessment of the sensory-discriminative pain severity status quo in real time.…”
Section: Discussionmentioning
confidence: 99%
“…The results of previous studies on the validity and accuracy of PD-Q in assessing neuropathic pain and post-traumatic trigeminal nerve injuries and distinguishing these conditions from non-neuropathic pain are variable. PD-Q has the potential to assist in triage of patients [26].…”
Section: Discussionmentioning
confidence: 99%
“…The PD-Q is scored on a scale from −1 to 38 where scores 19 or greater indicate likely presence of neuropathic pain, scores from 12 to 18 represent ambiguous pain, and scores below 12 represent a likelihood that neuropathic pain is not present. The PD-Q has been found to have high sensitivity, specificity, validity, and test-retest reliability in patients with low back pain and lumbosacral radiculopathy/radiculitis [ 4 , [58] , [59] , [60] , [61] , [62] ].…”
Section: Methodsmentioning
confidence: 99%